SPINAL MUSCULAR ATROPHY (SMA) COALITION

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2004–2008

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2008	—	1	1
2007	—	2	1
2006	—	1	1
2005	—	2	1
2004	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
WINNING STRATEGIES WASHINGTON	—	8

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	5
SENATE	5
Natl Institutes of Health (NIH)	4

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	7
Budget/Appropriations	Budget/Appropriations	1

Bills Explicitly Cited (5)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3334110th Congress

SMA Treatment Acceleration Act

2008 · first_quarter · Firm: WINNING STRATEGIES WASHINGTON

Open original LDA filing ↗

Cited source text and reported amounts

Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act

Client expense: — · Firm income: —

Matched citations: H.R. 3334

S. 2042110th Congress

SMA Treatment Acceleration Act

2008 · first_quarter · Firm: WINNING STRATEGIES WASHINGTON

Open original LDA filing ↗

Cited source text and reported amounts

Raising awareness and advocating for Spinal Muscular Atrophy (SMA) research; H.R. 3334, S. 2042 The SMA Treatment Acceleration Act

Client expense: — · Firm income: —

Matched citations: S. 2042

H.R. 3334110th Congress

SMA Treatment Acceleration Act

2007 · year_end · Firm: WINNING STRATEGIES WASHINGTON

Open original LDA filing ↗

Cited source text and reported amounts

Raising awareness and advocating for additional federal resources for Spinal Muscular Atrophy (SMA) research H.R. 3334, S. 2042 The SMA Treatment Acceleration Act

Client expense: — · Firm income: —

Matched citations: H.R. 3334

S. 2042110th Congress

SMA Treatment Acceleration Act

2007 · year_end · Firm: WINNING STRATEGIES WASHINGTON

Open original LDA filing ↗

Cited source text and reported amounts

Raising awareness and advocating for additional federal resources for Spinal Muscular Atrophy (SMA) research H.R. 3334, S. 2042 The SMA Treatment Acceleration Act

Client expense: — · Firm income: —

Matched citations: S. 2042

Show 1 more cited filings

H.R. 3334110th Congress

SMA Treatment Acceleration Act

2007 · mid_year · Firm: WINNING STRATEGIES WASHINGTON

Open original LDA filing ↗

Cited source text and reported amounts

Raising awareness and advocating for additional federal resources for Spinal Muscular Atrophy (SMA) research H.R. 3334, “The SMA Treatment Acceleration Act”

Client expense: — · Firm income: —

Matched citations: H.R. 3334

Source: Senate LDA

SPINAL MUSCULAR ATROPHY (SMA) COALITION — Lobbying Disclosure | Poliscope